IDYA
USDIDEAYA Biosciences Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$29.440
Kõrge
$30.450
Madal
$28.840
Maht
0.19M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
2.7B
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
1.21M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
IDEAYA Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, provided a business update and announced financial results...
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics,...
IDEAYA Biosciences to Participate in Upcoming November 2025 Investor Relations Events
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics,...
JP Morgan Maintains Overweight on IDEAYA Biosciences, Raises Price Target to $79
JP Morgan analyst Anupam Rama maintains IDEAYA Biosciences with a Overweight and raises the price target from $74 to $79.
Goldman Sachs Maintains Neutral on IDEAYA Biosciences, Raises Price Target to $30
Goldman Sachs analyst Corinne Jenkins maintains IDEAYA Biosciences with a Neutral and raises the price target from $27 to $30.
RBC Capital Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $41
RBC Capital analyst Leonid Timashev maintains IDEAYA Biosciences with a Outperform and raises the price target from $38 to $41.
BTIG Reiterates Buy on IDEAYA Biosciences, Maintains $62 Price Target
BTIG analyst Justin Zelin reiterates IDEAYA Biosciences with a Buy and maintains $62 price target.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.